Antimicrobial Resistance Practice Questions

Q: Most of the drug resistance occurs due to:

Conjugation. **Explanation:** The correct answer is **Conjugation**. In medical microbiology, drug resistance is primarily spread through **Horizontal Gene Transfer (HGT)**. Among the various mechanisms, **Conjugation** is the most significant and frequent method for the dissemination of multi-drug resistance (MDR). It involves the direct transfer of genetic material (usually **R-plasmids**) between two bacteria through a sex pilus. This process is highly efficient because it can occur between different species and allows for the simultaneous transfer of multiple resistance genes (e.g., against aminoglycosides, penicillins, and tetracyclines). **Why other options are incorrect:** * **Mutation:** While mutations in the bacterial chromosome can lead to resistance (e.g., *M. tuberculosis*), they occur spontaneously at a low frequency ($10^{-7}$ to $10^{-9}$) and usually provide resistance to only one drug at a time. * **Transduction:** This involves DNA transfer via a bacteriophage. While clinically relevant (e.g., penicillin resistance in *Staphylococcus aureus*), it is limited by the host range of the virus and is less common than conjugation. * **Translation:** This is a protein synthesis process, not a mechanism for genetic transfer or the acquisition of new resistance genes. **Clinical Pearls for NEET-PG:** * **Conjugation** is the primary reason for the rapid spread of resistance in **Gram-negative bacilli** (Enterobacteriaceae). * **Transformation** (uptake of naked DNA) is the classic mechanism for penicillin resistance in *Streptococcus pneumoniae*. * **Transposons** ("Jumping genes") often carry resistance genes and can move between the chromosome and plasmids, further facilitating conjugation. * **R-Plasmids** consist of two parts: the **RTF** (Resistance Transfer Factor) responsible for transfer and the **r-determinant** which carries the resistance genes.

Q: Why is urethral Mycoplasma genitalium infection often resistant to azithromycin treatment?

It acquires mutations in the 23S rRNA gene. ***Correct: It acquires mutations in the 23S rRNA gene*** - **Azithromycin** is a macrolide antibiotic that binds to the bacterial **23S ribosomal RNA (rRNA)** within the 50S ribosomal subunit, inhibiting protein synthesis. - *Mycoplasma genitalium* develops resistance through **point mutations** at positions 2058 and 2059 in the 23S rRNA gene, preventing effective drug binding to the ribosome. - These mutations are the **primary mechanism** of azithromycin resistance in *M. genitalium* and are increasingly prevalent, making treatment challenging. *Incorrect: It produces beta-lactamase enzymes* - **Beta-lactamase enzymes** hydrolyze the beta-lactam ring and confer resistance to **beta-lactam antibiotics** (penicillins, cephalosporins). - **Azithromycin is a macrolide**, not a beta-lactam, so beta-lactamase production is irrelevant to its mechanism of action. - Additionally, *Mycoplasma* species **lack a cell wall**, making them inherently resistant to beta-lactam antibiotics regardless of enzyme production. *Incorrect: It has intrinsic antimicrobial efflux pumps* - While **efflux pumps** can contribute to antibiotic resistance in various bacteria by actively expelling drugs from the cell, this is **not the primary mechanism** of azithromycin resistance in *M. genitalium*. - The dominant and clinically significant resistance mechanism is **chromosomal mutations in the 23S rRNA gene**, not efflux-mediated resistance. *Incorrect: It forms biofilms in the urethra* - **Biofilm formation** can protect bacteria from antibiotics and immune responses, contributing to persistent infections. - However, **biofilm formation is not the main mechanism** of azithromycin resistance in *M. genitalium*; the primary cause is **specific ribosomal target-site mutations** that prevent drug binding.

Q: Which bacterial component is critical for the antibiotic resistance of N. gonorrhoeae to penicillin?

Altered PBP2 (penA gene mutations). ***Altered PBP2 (penA gene mutations)*** - **Mutations in the *penA* gene** lead to changes in **penicillin-binding protein 2 (PBP2)**, reducing its affinity for penicillin and other beta-lactam antibiotics. - This reduced binding affinity prevents penicillin from effectively inhibiting **cell wall synthesis**, allowing *N. gonorrhoeae* to resist its bactericidal effects. *Beta-lactamase enzyme* - While beta-lactamase (specifically **penicillinase**) produced by some *N. gonorrhoeae* strains can **hydrolyze the beta-lactam ring** of penicillin, it is not the *critical* and most prevalent mechanism for **high-level penicillin resistance** in current strains. - The evolution of resistance has largely shifted from beta-lactamase production to **PBP mutations**. *Ribosomal protection proteins* - These proteins are primarily associated with resistance to **macrolide antibiotics** and tetracyclines, not penicillins. - They work by binding to the ribosome and **preventing antibiotic interference** with protein synthesis. *Efflux pump system* - Efflux pumps contribute to resistance by actively **expelling antibiotics** from the bacterial cell, thereby preventing them from reaching their intracellular targets. - While efflux pumps can play a role in **multi-drug resistance**, they are not the primary mechanism for penicillin resistance in *N. gonorrhoeae*.

Q: Why does Mycoplasma genitalium show a higher rate of antimicrobial resistance compared to other STI pathogens?

Due to rapid mutation in the 23S rRNA gene. ***Due to rapid mutation in the 23S rRNA gene*** [1] - *Mycoplasma genitalium* develops **resistance to macrolides**, a primary treatment, through **point mutations in the 23S rRNA gene** [1]. - These mutations alter the ribosomal binding site, preventing macrolide antibiotics from inhibiting **bacterial protein synthesis** [2]. *Due to plasmid exchange with other bacteria* - *Mycoplasma genitalium* **lacks a cell wall** and generally does not engage in significant plasmid exchange, which is a common mechanism for horizontal gene transfer and resistance acquisition in many other bacteria. - While other bacteria acquire resistance through plasmids, this mechanism is **not prominent** in *Mycoplasma genitalium*. *Due to absence of cell wall making beta-lactams ineffective* - The **absence of a cell wall** inherently makes beta-lactam antibiotics ineffective against *Mycoplasma genitalium*, as **beta-lactams target cell wall synthesis**. - However, this is a **natural resistance** and does not explain its higher rate of acquired antimicrobial resistance to other classes of antibiotics, such as macrolides. *Due to biofilm formation protecting from antibiotics* - While **biofilm formation can protect bacteria** from antibiotics, it is not the primary or most notable mechanism explaining the high rate of acquired resistance in *Mycoplasma genitalium*. - The major concern for *M. genitalium* resistance lies in **specific genetic mutations** affecting relevant antibiotic targets.

Q: Which antimicrobial resistance mechanism is most commonly associated with extended-spectrum cephalosporin resistance in Neisseria gonorrhoeae?

PenA mosaic alleles. ***PenA mosaic alleles*** - **PenA mosaic alleles** are altered forms of the gene encoding **penicillin-binding protein 2 (PBP2)**, which is the primary target of cephalosporin antibiotics in *Neisseria gonorrhoeae*. These mosaic alleles result from recombination events with homologous genes from commensal *Neisseria* species. - The altered PBP2 has **reduced affinity for cephalosporins**, making the bacteria resistant to this class of antibiotics, including extended-spectrum cephalosporins. *mtrR promoter mutation* - A **mutation in the *mtrR* promoter** typically leads to overexpression of the **MtrCDE efflux pump**, which pumps out various antimicrobial agents, including some macrolides, disinfectants, and bile salts. - While it contributes to multidrug resistance, its primary role is not in mediating high-level resistance to extended-spectrum cephalosporins in *N. gonorrhoeae*. *23S rRNA methylation* - **23S rRNA methylation** is a common mechanism of resistance to **macrolide antibiotics** (e.g., azithromycin), which bind to the 50S ribosomal subunit. - This mechanism interferes with macrolide binding to the ribosome, but it does not directly affect the activity of cephalosporins, which target bacterial cell wall synthesis. *TetM plasmid* - The **TetM plasmid** confers resistance to **tetracycline antibiotics** by protecting the bacterial ribosome from their action. TetM is a ribosomal protection protein. - This plasmid is a well-known mechanism of tetracycline resistance in many bacteria, including *N. gonorrhoeae*, but it is not involved in resistance to cephalosporins.

Question 1

What is the most common mechanism for the transfer of resistance in Staphylococcus aureus?

Accepted Answer

Transduction

Answer

Conjugation

Answer

Transformation

Answer

Mutation

Question 2

All of the following statements about Penicillin resistance are true, EXCEPT?

Accepted Answer

Alteration in target PBPs is an important resistance mechanism in Gram-negative bacteria.

Answer

Beta-lactamase production is the most common mechanism of resistance.

Answer

Alteration in permeability/penetration of antibiotic causes resistance only in Gram-negative bacteria.

Answer

Beta-lactamase production causes resistance in both Gram-positive and Gram-negative bacteria.

Question 3

Which statement is NOT TRUE regarding antibiotic resistance in bacteria?

Accepted Answer

Plasmid-mediated resistance is transmitted only vertically.

Answer

The most common mechanism is the production of antibiotic-destroying enzymes.

Answer

Lack of a target binding site may be a mechanism of resistance in some enterococci against vancomycin.

Answer

Target binding site alteration is the mechanism in some pneumococci.

Question 4

Which of the following is NOT true of transferable drug resistance?

Accepted Answer

Can be prevented by drug combinations

Answer

Multiple drug resistance simultaneously

Answer

Virulence of bacteria is unchanged

Answer

Can occur to a very high degree

Question 5

Most of the drug resistance occurs due to:

Accepted Answer

Conjugation

Answer

Transduction

Answer

Translation

Answer

Mutation

Question 6

Why is urethral Mycoplasma genitalium infection often resistant to azithromycin treatment?

Accepted Answer

It acquires mutations in the 23S rRNA gene

Answer

It produces beta-lactamase enzymes

Answer

It has intrinsic antimicrobial efflux pumps

Answer

It forms biofilms in the urethra

Question 7

Which of the following statements about antibiotic resistance in N. gonorrhoeae is FALSE?

Accepted Answer

Tetracycline resistance is primarily mediated by beta-lactamase production

Answer

Ceftriaxone resistance typically involves alterations in the penA gene

Answer

Resistance to fluoroquinolones is often due to mutations in gyrA and parC genes

Answer

Spectinomycin resistance remains extremely rare globally

Question 8

Which bacterial component is critical for the antibiotic resistance of N. gonorrhoeae to penicillin?

Accepted Answer

Altered PBP2 (penA gene mutations)

Answer

Beta-lactamase enzyme

Answer

Ribosomal protection proteins

Answer

Efflux pump system

Question 9

Why does Mycoplasma genitalium show a higher rate of antimicrobial resistance compared to other STI pathogens?

Accepted Answer

Due to rapid mutation in the 23S rRNA gene

Answer

Due to plasmid exchange with other bacteria

Answer

Due to absence of cell wall making beta-lactams ineffective

Answer

Due to biofilm formation protecting from antibiotics

Question 10

Which antimicrobial resistance mechanism is most commonly associated with extended-spectrum cephalosporin resistance in Neisseria gonorrhoeae?

Accepted Answer

PenA mosaic alleles

Answer

mtrR promoter mutation

Answer

23S rRNA methylation

Answer

TetM plasmid

Antimicrobial Resistance — MCQs

Antimicrobial Resistance — MCQs

On this page

Practice by Chapter

Want unlimited practice?